Chiesi USA Inc.
Cary, NC
- UEI
- M3FAV5PM8B15
- CAGE
- 483E9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 175 Regency Wds Pl #600, Cary, NC 27518, USA
- Website
- chiesiusa.com
- Founded
- 1935
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Sanofi Genzyme | Cambridge, MA | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Summit SD LLC | Lee's Summit, MO | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
| Supernus Pharmaceuticals, Inc. | Rockville, MD | 325412 Pharmaceutical Preparation Manufacturing |
| TG Therapeutics Inc. | Morrisville, NC | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Chiesi USA Inc. is a specialty pharmaceutical company that provides medical solutions to healthcare providers and patients. Through its GSA Schedule contract for pharmaceuticals and drugs, Chiesi USA Inc. supplies the Department of Veterans Affairs with medications used to treat conditions like iron overload and anemia in veterans.
Chiesi USA Inc. has been awarded multiple federal contracts to provide pharmaceutical products, primarily deferiprone and luspatercept, to Veterans Health Administration networks and facilities. These firm fixed price delivery orders issued against Chiesi's schedule contract supply deferiprone tablets in 1000mg doses to VA networks including VISN 5, VISN 12, and VISN 22. Chiesi has also received a $18,987 purchase order from VHA VISN 17 for the iron chelating drug Ferriprox. Additionally, the VA's National Acquisition Center established a $2.25 million blanket purchase agreement with Chiesi for the procurement of Ferriprox and Revcovi to streamline the acquisition process of these drugs.
Chiesi USA Inc. holds an indefinite-delivery/indefinite-quantity Federal Supply Schedule contract for pharmaceuticals and drugs with a potential value of $27.7 million. Task orders issued against this multiple award vehicle facilitate the delivery of deferiprone tablets to locations in Cary, North Carolina in support of VA medical programs. The contract runs through August 2025. By establishing these contracting mechanisms, the Department of Veterans Affairs acquires critical pharmaceutical products from Chiesi to serve healthcare needs of veterans.
Quick answers
Is Chiesi USA Inc. registered in SAM.gov?
Yes. Chiesi USA Inc.'s SAM.gov registration is active through September 18, 2027.
What is Chiesi USA Inc.'s CAGE code?
Chiesi USA Inc.'s CAGE code is 483E9, and its Unique Entity ID (UEI) is M3FAV5PM8B15.
Which contract vehicles does Chiesi USA Inc. hold?
Chiesi USA Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Chiesi USA Inc.'s most recent federal award?
Chiesi USA Inc.'s most recent federal contract award is Deferiprone 1000 MG (36C24522N0311), from Veterans Integrated Service Network 5 (VHA), on February 17, 2022.
On GovTribe
See Chiesi USA Inc.'s full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors